Search research articles
Contact Us
Filters
Showing results (81-90 of 83) with videos related to
Page
of 9
Sort By:
You have reached the last page of results.
This site can display upto 83 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 1, 2021
Management of Immune-Related Adverse Events in Patients Treated With Chimeric Antigen Receptor T-Cell Therapy: ASCO Guideline
Bianca D Santomasso, Loretta J Nastoupil, Sherry Adkins, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 15, 2022
Praluzatamab Ravtansine, a CD166-Targeting Antibody-Drug Conjugate, in Patients with Advanced Solid Tumors: An Open-Label Phase I/II Trial
Valentina Boni, Mary J Fidler, Hendrik-Tobias Arkenau, et al.
Nature Biotechnology
|
December 18, 2018
Deep learning using tumor HLA peptide mass spectrometry datasets improves neoantigen identification
Brendan Bulik-Sullivan, Jennifer Busby, Christine D Palmer, et al.
Page
of 9
Search research articles
Search
Showing results (81-90 of 83) with videos related to
Sort By:
Page
of 9
You have reached the last page of results.
This site can display upto 83 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 1, 2021
Management of Immune-Related Adverse Events in Patients Treated With Chimeric Antigen Receptor T-Cell Therapy: ASCO Guideline
Bianca D Santomasso, Loretta J Nastoupil, Sherry Adkins, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 15, 2022
Praluzatamab Ravtansine, a CD166-Targeting Antibody-Drug Conjugate, in Patients with Advanced Solid Tumors: An Open-Label Phase I/II Trial
Valentina Boni, Mary J Fidler, Hendrik-Tobias Arkenau, et al.
Nature Biotechnology
|
December 18, 2018
Deep learning using tumor HLA peptide mass spectrometry datasets improves neoantigen identification
Brendan Bulik-Sullivan, Jennifer Busby, Christine D Palmer, et al.
Page
of 9